FDA warns of reduced Plavix efficacy in poor metabolizers - ONA
Links shared publicly online about this topic.
- 1,313total visits
FDA warns of reduced Plavix efficacy in poor metabolizers - ONA
View full resource at oncologynurseadvisor.com
Tags: Healthcare, FDA, Anti-Clotting Medication, Plavix, Iscover, Sanofi-Aventis, Bristol-Myers Squibb
Most Recently Shared on March 15, 2010 at 1:21 pm By:
FDA warns of reduced Plavix efficacy in poor metabolizers http://goo.gl/fb/WOfc
FDA warns of reduced Plavix efficacy in poor metabolizers - MPR
empr.com — “The FDA has notified healthcare professionals and patients that a Boxed Warning has been added to the Plavix (clopidogrel tablets, from Bristol-Myers Squibb and Sanofi) Prescribing Information to include information about reduced Plavix efficacy in patients who are poor metabolizers of Plavix.” View full resource at empr.com
Most Recently Shared on March 15, 2010 at 1:27 pm By:
MPR News: FDA warns of reduced Plavix efficacy in poor metabolizers: The FDA has notified healthcare professionals... http://bit.ly/bdBhZq
Plavix gets new FDA warning | Reuters
reuters.com — “WASHINGTON (Reuters) - The blockbuster anti-clotting drug Plavix will carry a new warning about patients who have a poor response to the drug because they do not break it down well, U.S. regulators said” View full resource at reuters.com
Most Recently Shared on March 12, 2010 at 11:58 pm By:
Plavix gets new FDA warning regarding reduced efficacy in 3% slow activators. http://bit.ly/9ZrsNY
FDA Drug Safety Communication: Reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug
fda.gov — “[03-12-2010] The U.S. Food and Drug Administration (FDA) has added a Boxed Warning to the label for Plavix, the anti-blood clotting medication.” View full resource at fda.gov
Most Recently Shared on March 12, 2010 at 4:28 pm By:
Miriam E. Tucker Patient Expert
RT @FDA_Drug_Info: Reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug. http://bit.ly/PlavCYP
Advertisement
